GeoVax Labs, Inc. (NASDAQ: GOVX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $18.00 price target on the stock.
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK [Yahoo! Finance]
GeoVax Labs, Inc. (NASDAQ: GOVX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $18.00 price target on the stock.
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness [Yahoo! Finance]
GeoVax to Present at the Emerging Growth Conference on February 19, 2025 [Yahoo! Finance]